AJANTA PHARMA USA INC. C/O RXCROSSR — Captopril Importer Profile
Pharmaceutical Importer · #2 buyer for Captopril · $364.3K import value · 55 shipments · UNITED STATES · DGFT Verified
AJANTA PHARMA USA INC. C/O RXCROSSR is the #2 importer of Captopril from India with $364.3K in import value and 55 verified shipments. AJANTA PHARMA USA INC. C/O RXCROSSR holds a 9.2% market share in Captopril imports based in UNITED STATES. The company sources from 1 verified supplier across 39 formulations shipped to 1 country. Overall, AJANTA PHARMA USA INC. C/O RXCROSSR imports 3 pharmaceutical products worth $3.4M across 3 therapeutic categories.
AJANTA PHARMA USA INC. C/O RXCROSSR — Captopril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Captopril to AJANTA PHARMA USA INC. C/O RXCROSSR?
Verified from 55 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AJANTA PHARMA LIMITED | $364.3K | 55 | 100.0% |
AJANTA PHARMA USA INC. C/O RXCROSSR sources Captopril from 1 verified Indian supplier based on 55 customs records. The primary supplier is AJANTA PHARMA LIMITED accounting for 100.0% of imports.
How Does AJANTA PHARMA USA INC. C/O RXCROSSR Compare to Nearest Captopril Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AJANTA PHARMA USA INC. C/O RXCROSSR ★ | UNITED STATES | $1.1M | 42 | $27.3K |
| 3 | HEKO PHARMACY LTD | TANZANIA | $336.7K | 10 | $33.7K |
| 5 | UNIQUE PHARMA, | CONGO DR | $232.1K | 5 | $46.4K |
AJANTA PHARMA USA INC. C/O RXCROSSR ranks #2 among 170 Captopril importers from India. Average shipment value of $27.3K compared to the market average of $17.2K. The closest competitors by value are HEKO PHARMACY LTD and UNIQUE PHARMA,.
Where Does AJANTA PHARMA USA INC. C/O RXCROSSR Import Captopril To?
Destination countries from 55 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $364.3K | 55 | 100.0% |
AJANTA PHARMA USA INC. C/O RXCROSSR imports Captopril to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $364.3K.
What Captopril Formulations Does AJANTA PHARMA USA INC. C/O RXCROSSR Import?
| Formulation | Value | Shipments |
|---|---|---|
| CAPTOPRIL TABLETS USP 100 MG[NET WT.OF BULK DRUG CAPTOPRIL USP IS 13.200 KGS][1320PACX100=132000TABS]CONT.AS PER INVOICE | $50.0K | 1 |
| CAPTOPRIL TABLETS USP 50MG[NETWT.OF BULKDRUG CAPTOPRIL USP IS 40.560KGS][8112PACx1X100=811200TABLETS]CONT.AS PER DOCUMENT | $28.7K | 1 |
| CAPTOPRIL TABLETS USP 25MG[5808PACx1X100 | $24.3K | 2 |
| CAPTOPRIL TABLETS USP 50 MG[3636PACx100= | $23.1K | 2 |
| CAPTOPRIL TABLETS USP 50MG[NETWT.OF BULKDRUG CAPTOPRIL USP IS 25.200KGS][5040PACx1X100=504000TABLETS]CONT.AS PER DOCUMENT | $17.8K | 1 |
| CAPTOPRIL TABLETS USP 50MG[4104PACx100=4 | $14.5K | 1 |
| CAPTOPRIL TABLETS USP 25MG[5724PACx1X100=572400 TABLETS][NET WT.OF BULK DRUG CAPTOPRIL USP IS 14.310 KGS]CONT.AS PER INV | $12.3K | 1 |
| CAPTOPRIL TABLETS USP 25MG[5772PACx1X100=577200 TABLETS][NET WT.OF BULK DRUG CAPTOPRIL USP IS 14.430KGS]CONT.AS PER INV. | $12.2K | 1 |
| CAPTOPRIL TABLETS USP 25MG[NET WT.OF BULK DRUG CAPTOPRIL USP IS 14.400KGS][5760PACX1X100=576000 TABS]CONT.AS PER INVOICE | $12.1K | 3 |
| CAPTOPRIL TABLETS USP 25MG[5688PACX1X100=568800 TABLETS]NETWT.OF BULKDRUG CAPTOPRIL USP IS 14.220KGS]CONT.AS PER INVOICENOS | $11.9K | 3 |
AJANTA PHARMA USA INC. C/O RXCROSSR imports 39 distinct Captopril formulations from India. The top formulation is CAPTOPRIL TABLETS USP 100 MG[NET WT.OF BULK DRUG CAPTOPRIL U with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Captopril into United States
What AJANTA PHARMA USA INC. C/O RXCROSSR and other importers must comply with to import Captopril from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Captopril
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Captopril from India and How Much Does AJANTA PHARMA USA INC. C/O RXCROSSR Import?
India exported $2.9M worth of Captopril through 517 shipments from 109 suppliers to 63 countries, serving 170 buyers globally. AJANTA PHARMA USA INC. C/O RXCROSSR imports $364.3K of this total, accounting for 9.2% of India's Captopril exports with 55 shipments from UNITED STATES. This is verified from 55 customs shipment records covering 39 distinct formulations.
What Is the Average Order Value for AJANTA PHARMA USA INC. C/O RXCROSSR's Captopril Imports?
AJANTA PHARMA USA INC. C/O RXCROSSR's average Captopril order value is $6.6K per consignment, based on 55 shipments totaling $364.3K. AJANTA PHARMA USA INC. C/O RXCROSSR is based in UNITED STATES and ranks #2 among all Captopril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Captopril to AJANTA PHARMA USA INC. C/O RXCROSSR?
AJANTA PHARMA USA INC. C/O RXCROSSR sources Captopril from 1 verified Indian supplier: AJANTA PHARMA LIMITED ($364.3K, 100.0%). This is based on 55 customs records.
How Does AJANTA PHARMA USA INC. C/O RXCROSSR Compare to Other Captopril Importers?
AJANTA PHARMA USA INC. C/O RXCROSSR ranks #2 among 170 Captopril importers from India with a 9.2% market share. The top 3 importers are AJANTA PHARMA USA INC. C/O RXCROSSR ($1.1M), HEKO PHARMACY LTD ($336.7K), UNIQUE PHARMA, ($232.1K). AJANTA PHARMA USA INC. C/O RXCROSSR processed 55 shipments from UNITED STATES.
About AJANTA PHARMA USA INC. C/O RXCROSSR
AJANTA PHARMA USA INC. C/O RXCROSSR imports 3 products worth $3.4M. Beyond Captopril, top products include Fenofibrate, Voriconazole. View the complete AJANTA PHARMA USA INC. C/O RXCROSSR profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Captopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Captopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AJANTA PHARMA USA INC. C/O RXCROSSR matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AJANTA PHARMA USA INC. C/O RXCROSSR's capped import value divided by total capped export value for Captopril across all Indian exporters.
- 5.Verified Records: This page is backed by 55 individual customs records matching AJANTA PHARMA USA INC. C/O RXCROSSR importing Captopril, covering 39 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 170+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Captopril Import Data for AJANTA PHARMA USA INC. C/O RXCROSSR
Access order-level details, pricing data, supplier connections, and competitive analysis for AJANTA PHARMA USA INC. C/O RXCROSSR's Captopril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AJANTA PHARMA USA INC. C/O RXCROSSR
Full Company Profile →
3 products · $3.4M total trade · 3 categories
AJANTA PHARMA USA INC. C/O RXCROSSR × Captopril
Verified from customs records
Company Overview
Top Products by AJANTA PHARMA USA INC. C/O RXCROSSR
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AJANTA PHARMA USA INC. C/O RXCROSSR.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Captopril. For current order-level data, contact TransData Nexus.